A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease
Masahiro Jinzaki, Masaharu Hirano, Kazuhiro Hara, Takahiko Suzuki, Akira Yamashina, Yuji Ikari, Misako Iino, Takuhiro Yamaguchi, Sachio Kuribayashi
研究成果: Article › 査読
10
被引用数
(Scopus)